The Effect of Education Given to Individuals With Hypertension by Mobile Phone

The Effect of Education Given to Individuals With Hypertension by Mobile Phone on DASH Diet Compliance, Quality of Life, Mindfulness and Stress

This study was planned as randomized controlled trial in order to evaluate the effect of the mobile education given to the individuals with hypertension on DASH diet compliance, healthy lifestyle behaviours, quality of life, mindfulness and stress levels.

The study was conducted as a randomized controlled trial with 134 individuals with hypertension (68 experimental, 66 controlled) who applied a university hospital in Edirne between the dates on 20.01.2022 and 18.05.2023. The data were collected by "Patient Information Form", "Healthy Lifestyle Behaviour Scale II", "EQ-5D General Quality of Life Scale", "Mindful Attention Awareness Scale" and "Percieved Stress Scale" were used. An education application was installed on the mobile phones of the experimental group. Individuals with hypertension were provided with a training for three months through the mobile application. Data collection forms were filled in by the individuals with hypertension in the experimental and controlled groups at the beginning and at the 3rd month via the mobile application. The data were analyzed in SPSS 26 (Statistical Package for the Social Sciences) program with the Shapiro-Wilk test, Student's t-test, Paired-Sample t-test, Chi-Square test, Fisher's Exact test, Fisher-Freeman-Halton test and Pearson correlation coefficient. The results were evaluated at % 95 confidence interval and the significance was evaluated at p<0,05 level.

Study Overview

• Status: Completed
• Conditions: Hypertension; Mobile Education
• Intervention / Treatment: Other: mobile education

• Study Type: Interventional
• Enrollment (Actual): 134
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Merkez
    • Edirne, Merkez, Turkey, 22030
      • Trakya Üniversitesi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Those diagnosed with Primary Hypertension (at least 1 month ago),
• Over 18 years,
• No communication barriers,
• Being literate,
• Volunteering to participate in the research,
• Individuals with hypertension who own a smartphone.

Exclusion Criteria:

• under 18 years old,
• Having a communication barrier,
• Those with chronic kidney disease,
• Individuals with hypertension and heart failure.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Mobile Education; An education application was installed on the mobile phones of the experimental group. Individuals with hypertension were provided with a training for three months through the mobile application. Data collection forms were filled in by the individuals with hypertension in the experimental and controlled groups at the beginning and at the 3rd month via the mobile application.

Other: mobile education; The study was conducted as a randomized controlled trial with 134 individuals with hypertension (68 experimental, 66 controlled) who applied a university hospital. The data were collected by "Patient Information Form", "Healthy Lifestyle Behaviour Scale II", "EQ-5D General Quality of Life Scale", "Mindful Attention Awareness Scale" and "Percieved Stress Scale" were used. An education application was installed on the mobile phones of the experimental group. Individuals with hypertension were provided with a training for three months through the mobile application. Data collection forms were filled in by the individuals with hypertension in the experimental and controlled groups at the beginning and at the 3rd month via the mobile application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mobile Education	The education given to individuals with hypertension via mobile phone was evaluated with healthy lifestyle behaviors, quality of life, stress and awareness scales.	three months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Healty Lifestyle Behaviour	The education given to individuals with hypertension via mobile phone was evaluated with the healthy lifestyle behaviors scale II.	three months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of Life (EQ-5D General Quality of Life Scale)	The education given to individuals with hypertension via mobile phone was evaluated with EQ-5D General Quality of Life Scale.	three months
Stress	The education given to individuals with hypertension via mobile phone was evaluated with Percieved Stress Scale .	three months
Mindfulness	The education given to individuals with hypertension via mobile phone was evaluated with Mindful Attention Awareness Scale.	three months

Collaborators and Investigators

• Sponsor: Trakya University

Study record dates

Study Major Dates

• Study Start (Actual): January 20, 2022
• Primary Completion (Actual): May 18, 2023
• Study Completion (Actual): August 10, 2023

Study Registration Dates

• First Submitted: September 18, 2023
• First Submitted That Met QC Criteria: September 26, 2023
• First Posted (Actual): October 3, 2023

Study Record Updates

• Last Update Posted (Actual): October 3, 2023
• Last Update Submitted That Met QC Criteria: September 26, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Hypertension
• Other Study ID Numbers: 2021/128

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: It will be shared with the participants after it becomes published.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No